Nanogenics is proud to introduce LipTide™, a peptide-based vector, custom-built to target specific cells and deliver payloads for all gene therapy
United Kingdom
Joined April 2017
- Tweets291
- Following118
- Followers237
- Likes38
A visit from our Chief Scientific Officer and royalty in the same week. Why @edgehill University and its state-of-the-art labs are making waves in the #MedicalResearch community #GeneTherapy bit.ly/NanoGenics_EdgeHill
In his latest blog, our Chief Scientific Officer, @W12Newman explains why @edgehill University is the one to watch for #MedicalResearch advances, including our #GeneTargeting LipTide studies bit.ly/NanoGenics_EdgeHill
Animal studies have suggested amyotrophic lateral sclerosis #ALS can be prevented with #GeneTherapy - but delivery is the challenge. Learn more here via @newscientist bit.ly/2Qe85TS
Current #GeneTherapy solutions are held back by toxicity which makes repeat dosing unsafe. Our delivery system is targeted and well-tolerated. Learn more here bit.ly/LipTide
Researchers inspired by a young patient with an inherited cardiac arrhythmia disorder are now looking for a #GenomeEditing solution. Read on @EurekAlert: bit.ly/2Dy46Lg
WATCH: How our novel delivery system carries gene therapy to the target and is actively taken up by the cell here bit.ly/LipTide
An early study in #ParkinsonsDisease has shown #GeneTherapy can improve symptom control. Find out more via @medical_xpress here bit.ly/2DPs0Tc
The construction of LipTide sets it apart from #GeneTherapy vectors of the past. Learn about our artificial virus here bit.ly/LipTide
#GeneTherapy is a rapidly advancing field. @NatureNews reviews what has changed in the last 3 years and suggests a crucial part of shaping the future: go.nature.com/2PGZ1HB
Last month we saw devastating forest fires across the West of America. In the future, could fires like these be prevented by #GeneTherapy? Find out: bit.ly/2DOAWsg
For too long, the promise of #GeneTherapy has been held back by practical limitations. How do we aim to overcome this? Find out here bit.ly/NanoGenicsMission
"This is a tremendous validation of our technology." Dr Alan Walker commenting on the new #GeneTherapy study investigating the use of LipTide post-eye surgery. Read more here bit.ly/MolTherLipTide
The Cell Therapy Manufacturing & Gene Therapy Congress opens its doors today in Amsterdam. The agenda is packed with developments from innovators in #GeneTherapy @NextGen365 #CELLGENE More info here: bit.ly/2QXoh9b
#GeneTherapy breakthrough: delivery system developed for leading cause of blindness has shown positive results. Find out more here bit.ly/MolTherLipTide
Peptides on the outside of the LipTide structure ensure the #GeneTherapy payload is actively taken up by target cells. This enables repeatable regular dosing. Find out more here bit.ly/NanoGenicsLipTide
We are thrilled to announce the publication of a major new in vivo study which validates using #GeneTherapy after #glaucoma surgery. Read here bit.ly/MolTherLipTide
How can LipTide help solve the delivery challenges of #GeneTherapy? Find out here nanogenics.co.uk
LipTide can deliver any type of gene therapy incl. siRNA, mRNA and DNA payloads to the target cell. An MIT study has recently found using RNA could offer improved safety and easier delivery. Read more here via @techreview bit.ly/2PtOdM5
Has LipTide been used to deliver any #GeneTherapies yet? Yes, we have already had successful results in the lab in a range of diseases including #cancer. Learn more bit.ly/NanoGenicspipeline
